Blockchain Registration Transaction Record
Annovis Bio Welcomes New Executive Team Members
Annovis Bio (NYSE: ANVS) announces the addition of four new members to its executive team as it makes strides towards advancing its flagship drug candidate and bringing potential treatments for neurodegenerative disorders closer to market.
This news matters because it signifies a significant step forward for Annovis Bio in its mission to develop transformative therapies for neurodegenerative disorders. The addition of seasoned professionals to the executive team indicates the company's commitment to advancing its drug candidate and bringing potential treatments for Alzheimer's Disease and Parkinson's Disease closer to market.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xcbbbf643c601077a454fb3c16c0b0a2482c7377bbbb6eb1f61e57430638dcc23 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | gulfBoca-045f532f4967b8f9316ee2f30f5a0416 |